Stigmabase | HIV

Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

Posts

Showing posts matching the search for WHO Recommends High-Priced Drugs For Millions With Hepatitis C

Show all

WHO Recommends High-Priced Drugs For Millions With Hepatitis C

South Africa Time — Thursday, April 10, 2014

WHO Recommends High-Priced Drugs For Millions With Hepatitis C - The disease is common among people who are HIV positive. ... around 10 million people, most of them in the poorest countries of sub-Saharan Africa .

LEGACY - for researchers

JOHANNESBURG

Stigmabase is a canadian non-profit internet initiative dedicated to informing and raising awareness on the damaging effects of social exclusion and stigma around the world. The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

2010 - 2026 ― Stigmabase Global Initiative || Keeping up-to-date on global exclusion

ABOUT STIGMABASE
Request for Review